Back
Invesco S&P MidCap 400 Revenue ETF Vs. Bright Minds Biosciences Industry Stock Comparison
Buy
79
RWK
Invesco S&P MidCap 400 Revenue ETF
Last Price:
125.63
Seasonality Move:
5.06%
Sell
25
DRUG
Bright Minds Biosciences
Last Price:
47.40
Seasonality Move:
-15.89%
Buy
79
Invesco S&P MidCap 400 Revenue ETF (RWK)
is a Buy
Is Invesco S&P MidCap 400 Revenue ETF a Buy, Sell or Hold?
- The current Invesco S&P MidCap 400 Revenue ETF [RWK] share price is $125.63. The Score for RWK is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- RWK is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
- The current Bright Minds Biosciences [DRUG] share price is $44.00. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RWK Stock Price Chart
What is Invesco S&P MidCap 400 Revenue ETF's stock price today?
-
The Invesco S&P MidCap 400 Revenue ETF share price today is $125.63
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RWK is experiencing selling pressure, which indicates risk of future bearish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $44.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
RWK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.08 | Buy |
| Relative Strength Index (14 RSI): | 67.86 | Buy |
| Chaikin Money Flow: | -5119 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (117.04 - 123.96) | Buy |
| Bollinger Bands (100): | (111.34 - 119.68) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.5 | Buy |
| Relative Strength Index (14 RSI): | 58.93 | Buy |
| Chaikin Money Flow: | 115403 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.12 - 49.42) | Buy |
| Bollinger Bands (100): | (-5.11 - 34.85) | Buy |
RWK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 123.65 | Buy |
| 20-day SMA: | 121.52 | Buy |
| 50-day SMA: | 118.47 | Buy |
| 200-day SMA: | 113 | Buy |
| 8-day EMA: | 124.13 | Buy |
| 20-day EMA: | 121.94 | Buy |
| 50-day EMA: | 119.01 | Buy |
| 200-day EMA: | 112.45 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.17 | Buy |
| 20-day SMA: | 42.3 | Buy |
| 50-day SMA: | 28.61 | Buy |
| 200-day SMA: | 8.06 | Buy |
| 8-day EMA: | 39.27 | Buy |
| 20-day EMA: | 39.13 | Buy |
| 50-day EMA: | 31.07 | Buy |
| 200-day EMA: | 12.97 | Buy |
Invesco S&P MidCap 400 Revenue ETF Earnings Growth & RWK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Invesco S&P MidCap 400 Revenue ETF Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||